Eagle Materials (EXP) Form 4: Ellen Martin Granted 1,290 Restricted Shares
Rhea-AI Filing Summary
Form 4 filed for Eagle Materials, Inc. (EXP): On 08/04/2025 Director Ellen Martin M was granted 1,290 shares of restricted common stock at $0. The restrictions will lapse on 07/31/2026.
Following the reported transaction the filing shows 10,111 shares beneficially owned directly and 2,006 shares beneficially owned indirectly via Martin Robin Partners, L.P. The Form was executed by an attorney-in-fact and dated 08/06/2025.
Positive
- 1,290 restricted shares granted to Director Ellen Martin M on 08/04/2025 with a disclosed restriction lapse of 07/31/2026.
Negative
- None.
Insights
TL;DR: Routine director restricted-stock grant disclosed; vesting date and holdings update provided, limited immediate investor impact.
The Form 4 reports a 1,290-share restricted stock grant to Director Ellen Martin M on 08/04/2025 at a reported price of $0, with restrictions lapsing on 07/31/2026. The filing also updates beneficial ownership to 10,111 shares direct and 2,006 shares indirect via Martin Robin Partners, L.P. This is a standard equity compensation disclosure for an insider and does not indicate any sale or exercise activity. Impact: not impactful to valuation absent additional material disclosures.
TL;DR: Insider acquisition (grant) recorded; no proceeds received and no change to cash flow; holdings updated.
The transaction is coded as an acquisition (code A) of restricted common stock (1,290 shares) at $0 on 08/04/2025. Post-transaction beneficial ownership is listed as 10,111 direct and 2,006 indirect. The Form was signed by counsel on 08/06/2025. From a market perspective this filing documents compensation-related issuance to a director rather than trading activity; it therefore carries neutral informational value for short-term trading signals.
FAQ
What transaction did EXP director Ellen Martin M report on 08/04/2025?
How many EXP shares does Ellen Martin M beneficially own after the reported transaction?
When do the restrictions on the restricted shares lapse?
Was the Form 4 filed individually and who signed it?
What transaction code and price were reported for the acquisition?